Cells | Free Full-Text | The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure
DNA Methylation and Anticancer Drug Resistance in Gynecological Tumors
Frontiers | Sensing Soluble Immune Checkpoint Molecules and Disease-Relevant Cytokines in Cancer: A Novel Paradigm in Disease Diagnosis and Monitoring
Systemic immunity in cancer | Nature Reviews Cancer
Frontiers | The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy
Frontiers | Research progress in inducing immunogenic cell death of tumor cells
Emerging new therapeutic antibody derivatives for cancer treatment | Signal Transduction and Targeted Therapy
Frontiers | Therapeutic strategies for gastric cancer targeting immune cells: Future directions
Current Oncology | Free Full-Text | Current and Future Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
Frontiers | Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
Frontiers | Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia
Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma | Genes & Immunity
T follicular helper cells in cancer: Trends in Cancer
The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity | Cell Research
Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing: Molecular Therapy - Methods & Clinical Development
Arginine Supplementation Targeting Tumor-Killing Immune Cells Reconstructs the Tumor Microenvironment and Enhances the Antitumor Immune Response | ACS Nano
IJMS | Free Full-Text | Autoimmune Responses in Oncology: Causes and Significance
Immune Checkpoint Inhibitor Therapy in Oncology: Current Uses and Future Directions: JACC: CardioOncology State-of-the-Art Review | JACC: CardioOncology
Frontiers | What Happens to the Immune Microenvironment After PD-1 Inhibitor Therapy?
Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer | Cell Death & Disease
Life | Free Full-Text | An Immunological Perspective of Circulating Tumor Cells as Diagnostic Biomarkers and Therapeutic Targets
What Are Immune Checkpoints?
Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy | Signal Transduction and Targeted Therapy
